7 Key Takeaways from SMi’s 10th Annual Pharmaceutical Microbiology Conference
SMi Reports: SMi Group outlines seven key takeaways attendees can gain from joining the Pharmaceutical Microbiology Conference on 17 and 18 January 2021 in London, UK.
London, United Kingdom, November 28, 2021 --(PR.com)-- The 10th Annual Pharmaceutical Microbiology Conference will convene on the 17th and 18th January 2022 in London, UK. Developing on previous conference success, SMi's 10th Annual Pharmaceutical Microbiology Conference will bring together industry experts to discuss and analyse the latest advancements and challenges within pharmaceutical microbiology.
The two-day conference is led by senior microbiologists engaged in research and the 2022 event will provide an unmatched platform for the meaningful exchange of ideas dealing with delivering information on rapid microbial methods, sterility assurance, contamination control and mycoplasma testing, updates on Annex 1 and much more.
Interested parties can register for the conference and the two interactive workshops at http://www.pharma-microbiology.com/PR3. Register by 30th November to save £100.
SMi Group are delighted to share seven key takeaways which delegates stand to gain by attending this vital must attend conference:
1. Contamination Control Strategy - a wholistic way to maintain sterility assurance - delving into Current status of EU GMP Annex-1, Elements of a CCS and contaminants in scope and looking to CCS hierarchy, structure, and lifecycle by Boehringer Ingelheim
2. A risk assessment approach to address fungal spore contamination in a cell and gene therapy cleanroom from STERIS Corporation
3. Annex 1 and Environmental Monitoring Program - implementation and justification of the best practices in routine by Sanofi
4. A Sanofi Pasteur Mycoplasma techno roadmap and implementation of mycoplasma alternative method to release human vaccines, looking into regulatory background and Mycoplasma testing, development of NAT methods, validation of NAT method for mycoplasma testing and a roadmap and Implementation for new vaccines and commercialized product
5. Explore alternative endotoxin test methods for products exhibiting low current state of Pyrogen - and Endotoxin Testing presented by Paul Ehrlich Institute
6. Hear from AstraZeneca on applying virtual reality to training in aseptic processing and microbiology
7. Panel Debate discussion on Diversity in Science: the importance of workplace diversity in life sciences
The conference will be chaired by Conference Chair: Di Morris, Clinical Auditor, AstraZeneca
Featured Speakers Include:
• Karen Capper, Associate Director - Head of Microbiology, Pharmaceutical Development, AstraZeneca
• Suzanne Nutter, QA Group Manager, AstraZeneca
• Benoit Ramond, Head of Microbiology and Sterile Technologies, Sanofi
• Martin Müllner, Senior Quality Assurance Manager, Boehringer Ingelheim
• Jim Polarine, Senior Technical Service Manager, STERIS
• Thierry Bonnevay Global Microbiology Analytical Expert, Sanofi Pasteur
• Johannes Oberdörfer, Lead Scientist Rapid Microbiology Methods, Boehringer Ingelheim
• Peter Annel, Principal Scientist, Novo Nordisk
• Ingo Spreitzer, Deputy Head, Section 1/3 Microbiological Safety, Paul-Ehrlich-Institut
• Ren-Yo Forng, Scientific Director, Amgen
• Pratixa Patel, Head of Analytical, Microbiology, Stability & Product Chemistry, GSK
• Sven Deutschmann, Head of Global ASAT, Roche
• Andrew Davies, Managing Director, Microgenetics
• David Collins, Global Technical Consultant, Life Sciences, ECOLAB
• Shabnam Solati, CEO, CTL-MAT
The full agenda and speaker line-up is available to download online at http://www.pharma-microbiology.com/PR3
The conference is proudly sponsored by: C.T.L. Mat, ECOLAB, Microgenetics, Novatek and NPC
For sponsorship enquiries contact Alia Malick, Director on +44 (0)20 7827 6164 or amalick@smi-online.co.uk
For media enquiries and press pass requests, contact Simi Sapal, Head of Marketing on +44 (0) 20 7827 6162 or ssapal@smi-online.co.uk
SMi’s 10th Annual Pharmaceutical Microbiology Conference
Conference: 17 - 18 January 2022
Workshops: 19 January 2022
London, UK
http://www.pharma-microbiology.com/PR3
#SMiPharmaMicroUK
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk
The two-day conference is led by senior microbiologists engaged in research and the 2022 event will provide an unmatched platform for the meaningful exchange of ideas dealing with delivering information on rapid microbial methods, sterility assurance, contamination control and mycoplasma testing, updates on Annex 1 and much more.
Interested parties can register for the conference and the two interactive workshops at http://www.pharma-microbiology.com/PR3. Register by 30th November to save £100.
SMi Group are delighted to share seven key takeaways which delegates stand to gain by attending this vital must attend conference:
1. Contamination Control Strategy - a wholistic way to maintain sterility assurance - delving into Current status of EU GMP Annex-1, Elements of a CCS and contaminants in scope and looking to CCS hierarchy, structure, and lifecycle by Boehringer Ingelheim
2. A risk assessment approach to address fungal spore contamination in a cell and gene therapy cleanroom from STERIS Corporation
3. Annex 1 and Environmental Monitoring Program - implementation and justification of the best practices in routine by Sanofi
4. A Sanofi Pasteur Mycoplasma techno roadmap and implementation of mycoplasma alternative method to release human vaccines, looking into regulatory background and Mycoplasma testing, development of NAT methods, validation of NAT method for mycoplasma testing and a roadmap and Implementation for new vaccines and commercialized product
5. Explore alternative endotoxin test methods for products exhibiting low current state of Pyrogen - and Endotoxin Testing presented by Paul Ehrlich Institute
6. Hear from AstraZeneca on applying virtual reality to training in aseptic processing and microbiology
7. Panel Debate discussion on Diversity in Science: the importance of workplace diversity in life sciences
The conference will be chaired by Conference Chair: Di Morris, Clinical Auditor, AstraZeneca
Featured Speakers Include:
• Karen Capper, Associate Director - Head of Microbiology, Pharmaceutical Development, AstraZeneca
• Suzanne Nutter, QA Group Manager, AstraZeneca
• Benoit Ramond, Head of Microbiology and Sterile Technologies, Sanofi
• Martin Müllner, Senior Quality Assurance Manager, Boehringer Ingelheim
• Jim Polarine, Senior Technical Service Manager, STERIS
• Thierry Bonnevay Global Microbiology Analytical Expert, Sanofi Pasteur
• Johannes Oberdörfer, Lead Scientist Rapid Microbiology Methods, Boehringer Ingelheim
• Peter Annel, Principal Scientist, Novo Nordisk
• Ingo Spreitzer, Deputy Head, Section 1/3 Microbiological Safety, Paul-Ehrlich-Institut
• Ren-Yo Forng, Scientific Director, Amgen
• Pratixa Patel, Head of Analytical, Microbiology, Stability & Product Chemistry, GSK
• Sven Deutschmann, Head of Global ASAT, Roche
• Andrew Davies, Managing Director, Microgenetics
• David Collins, Global Technical Consultant, Life Sciences, ECOLAB
• Shabnam Solati, CEO, CTL-MAT
The full agenda and speaker line-up is available to download online at http://www.pharma-microbiology.com/PR3
The conference is proudly sponsored by: C.T.L. Mat, ECOLAB, Microgenetics, Novatek and NPC
For sponsorship enquiries contact Alia Malick, Director on +44 (0)20 7827 6164 or amalick@smi-online.co.uk
For media enquiries and press pass requests, contact Simi Sapal, Head of Marketing on +44 (0) 20 7827 6162 or ssapal@smi-online.co.uk
SMi’s 10th Annual Pharmaceutical Microbiology Conference
Conference: 17 - 18 January 2022
Workshops: 19 January 2022
London, UK
http://www.pharma-microbiology.com/PR3
#SMiPharmaMicroUK
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk
Contact
SMi Group
Simi Sapal
(0) 20 7827 6162
http://www.pharma-microbiology.com/PR3
Simi Sapal
(0) 20 7827 6162
http://www.pharma-microbiology.com/PR3
Contact
Categories